ABCAM PLC: Upcoming Abcam Investor Events

Rhea-AI Summary

Abcam plc, a leader in life science research tools, announced upcoming investor events to enhance communication with stakeholders. Chief Financial Officer Michael Baldock will present at the Bank of America 2023 Health Care Conference on May 9, 2023, at 10:40 AM PDT and at William Blair's 43rd Annual Growth Stock Conference on June 6, 2023, at 12:40 PM CDT. A live audio webcast of these presentations will be available on Abcam's investor website. Abcam, founded in 1998 and headquartered in Cambridge, UK, serves approximately 750,000 life science researchers globally, providing validated antibodies, assays, and other tools to support research and clinical goals, thereby advancing biology understanding and health improvements.

Positive

• Upcoming presentations at major investor conferences may increase visibility among investors.
• Abcam has a large and diverse customer base of approximately 750,000 life science researchers.

Negative

• None.

CAMBRIDGE, England and WALTHAM, Mass., April 17, 2023 /PRNewswire/ -- Abcam plc ("Abcam," "Company," "Group") (Nasdaq: ABCM), a global leader in the supply of life science research tools, today announces the following investor events.

•   Michael Baldock, Chief Financial Officer, will present at two upcoming investor conferences
•   Bank of America 2023 Health Care Conference on Tuesday, May 9 at 10:40am PDT
•   William Blair's 43^rd Annual Growth Stock Conference on Tuesday, June 6 at 12:40pm CDT

The live audio webcast will be available in the investor section of Abcam's corporate website at corporate.abcam.com/investors/reports-presentations/.  An archive will be available after the call at that same address.

About Abcam plc

As an innovator in reagents and tools, Abcam's purpose is to serve life science researchers globally to achieve their mission faster. Providing the research and clinical communities with tools and scientific support, the Company offers highly validated antibodies, assays, and other research tools to address important targets in critical biological pathways.

Already a pioneer in data sharing and ecommerce in the life sciences, Abcam's ambition is to be the most influential company in life sciences by helping advance global understanding of biology and causes of disease, which, in turn, will drive new treatments and improved health.

Abcam's worldwide customer base of approximately 750,000 life science researchers' uses Abcam's antibodies, reagents, biomarkers, and assays. By actively listening to and collaborating with these researchers, the Company continuously advances its portfolio to address their needs. A transparent program of customer reviews and datasheets, combined with industry-leading validation initiatives, gives researchers increased confidence in their results.

Founded in 1998 and headquartered in Cambridge, UK, the Company has served customers in more than 130 countries. Abcam's American Depositary Shares (ADSs) trade on the Nasdaq Global Select Market (Nasdaq: ABCM).

For more information, please visit www.abcam.com or www.abcamplc.com

For further information please contact:

Abcam plc
Tommy Thomas, CPA
Vice President, Investor Relations
+1 617-577-4205
152 Grove Street, Building 1100
Waltham, MA 02453
tommy.thomas@abcam.com
617-577-4205

Logo - https://mma.prnewswire.com/media/1670705/Abcam_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/abcam-plc-upcoming-abcam-investor-events-301797196.html

SOURCE Abcam PLC

FAQ

What are the upcoming investor events for Abcam?

Abcam will present at the Bank of America 2023 Health Care Conference on May 9, 2023, and at William Blair's 43rd Annual Growth Stock Conference on June 6, 2023.

Who will represent Abcam at the investor conferences?

Michael Baldock, Chief Financial Officer, will represent Abcam at the investor conferences.

How many life science researchers does Abcam serve?

Abcam serves approximately 750,000 life science researchers worldwide.

Where can I find the live audio webcast of Abcam's investor presentations?

The live audio webcast will be available on Abcam's investor website at corporate.abcam.com/investors/reports-presentations/